After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »
Refusing to self-isolate when told to is now illegal in England from Monday, with fines of up to £10,000. Anyone who tests positive for Covid-19, or has been told they have been in contact with someone who has, now has a legal duty to quarantine. It comes as a study commissioned by the government found… Read More »
News Consumer News FDA OKs Farxiga for Heart Failure With Reduced Ejection Fraction WEDNESDAY, May 6, 2020 — The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday. Farxiga is the first approved sodium-glucose cotransporter 2 inhibitor… Read More »
Sept. 24, 2018 — A tiny clip may be a big advance for millions of Americans battling severe heart failure, new research announced on Sunday suggests. Researchers say a device, called a mitral clip, inserted into the heart greatly lowered death rates for these patients. “It’s a huge advance,” Dr. Howard Herrmann, who directs interventional… Read More »